A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
Condition: Gastroesophageal RefluxIntervention: Drug: DexlansoprazoleSponsor: TakedaNot yet recruiting - verified November 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acid Reflux | Dexilant | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Pediatrics | Research | Study